NRG1 Fusion-Positive Lung Cancers: Clinicopathologic Profile and Treatment Outcomes from a Global Multicenter Registry

M. Duruisseaux (Lyon, France), A. Drilon (New York, United States of America), J. Han (Goyang, Republic of Korea), V. Gounant (Paris, France), J. Shih (Taipei, Taiwan), A. Schram (New York, United States of America), F. Magne (Villefranche-sur-saone, France), I. Monnet (Créteil, France), D. Moro-Sibilot (Grenoble, France), T. Blum (Berlin, Germany), T. Patil (Denver, United States of America), R. Doebele (Denver, United States of America), D. Camidge (Denver, United States of America), L. Muscarella (San Giovanni Rotondo, Italy), S. Liu (Washington, DC, United States of America), J. Cadranel (Paris, France)

Source: International Congress 2019 – Biology of lung cancer
Session: Biology of lung cancer
Session type: Poster Discussion
Number: 3666
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Duruisseaux (Lyon, France), A. Drilon (New York, United States of America), J. Han (Goyang, Republic of Korea), V. Gounant (Paris, France), J. Shih (Taipei, Taiwan), A. Schram (New York, United States of America), F. Magne (Villefranche-sur-saone, France), I. Monnet (Créteil, France), D. Moro-Sibilot (Grenoble, France), T. Blum (Berlin, Germany), T. Patil (Denver, United States of America), R. Doebele (Denver, United States of America), D. Camidge (Denver, United States of America), L. Muscarella (San Giovanni Rotondo, Italy), S. Liu (Washington, DC, United States of America), J. Cadranel (Paris, France). NRG1 Fusion-Positive Lung Cancers: Clinicopathologic Profile and Treatment Outcomes from a Global Multicenter Registry. 3666

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: